Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Biotech
Vor Bio to wind down, laying off most staff
The company is immediately winding down clinical and manufacturing operations and laying off 95% of staff.
Darren Incorvaia
May 8, 2025 10:50am
CEO invests own cash to move NKGen toward Alzheimer’s readout
May 8, 2025 10:22am
Korro lays off 20% to fund genetic med trials, Novo collab
May 8, 2025 10:00am
Neurocrine hands back 2 CNS gene therapy programs to Voyager
May 7, 2025 7:30am
Vertex takes $379M hit tied to cancelled islet cell program
May 6, 2025 12:50pm
Unity and Mammoth embark on restructurings, prompting layoffs
May 5, 2025 2:44pm
More News
J&J gene therapy fails ph. 3 rare eye disease trial
May 5, 2025 11:33am
Vertex discontinues AAV research for gene therapies
May 2, 2025 6:22pm
Caribou cuts 32% of staff, further purges cell therapy pipeline
Apr 24, 2025 9:55pm
NIH nixes financing for Pluri's radiation exposure cell therapy
Apr 18, 2025 9:10am
See more stories